Intrapace develops a novel implantable system to treat obesity.
Industries BiotechnologyHealth CareHealth DiagnosticsHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date 2001 Operating Status Active Last Funding Type Venture - Series Unknown
Company Type For Profit
Contact Email PR@intrapace.com Phone Number (650) 376-4070
IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any
limitations on what a person can eat or drink.